Co-Diagnostics (CODX) to Release Earnings on Thursday

Co-Diagnostics (NASDAQ:CODX) is scheduled to issue its quarterly earnings data after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of ($0.33) per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Co-Diagnostics (NASDAQ:CODX) last released its quarterly earnings data on Thursday, August 8th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.34) by $0.09. Co-Diagnostics had a negative net margin of 411.18% and a negative return on equity of 44.69%. The company had revenue of $2.66 million during the quarter, compared to analyst estimates of $0.40 million. On average, analysts expect Co-Diagnostics to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Co-Diagnostics Stock Up 0.8 %

Co-Diagnostics stock opened at $1.22 on Thursday. Co-Diagnostics has a 52-week low of $1.00 and a 52-week high of $2.23. The firm has a fifty day moving average of $1.30 and a 200-day moving average of $1.25. The firm has a market capitalization of $38.93 million, a P/E ratio of -0.92 and a beta of -0.87.

Analyst Ratings Changes

Separately, HC Wainwright dropped their price objective on shares of Co-Diagnostics from $2.00 to $1.50 and set a “neutral” rating for the company in a research report on Monday, August 12th.

About Co-Diagnostics

Co-Diagnostics, Inc, a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting.